Description
Salmeterol (salmeterol xinafoate) is a respiratory medications and inhalers agent listed in our Respiratory medications and inhalers directory and prescribed for specified asthma or reversible-airway conditions and chronic obstructive pulmonary disease (1.1) (2.1). Administered via the oral, respiratory (inhalation) route, Salmeterol is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Salmeterol is a medication containing the active pharmaceutical ingredient salmeterol xinafoate, classified pharmacologically as a respiratory medications and inhalers agent (2.1). It is clinically indicated for the management of specified asthma or reversible-airway conditions and chronic obstructive pulmonary disease as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Respiratory medications and inhalers section of our catalogue, patients and prescribers frequently review Salmeterol alongside related therapies such as Serevent (Salmeterol Xinafoate), Acetylcysteine, Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), and Advair (Fluticasone Propionate / Salmeterol Xinafoate).
Official Indications and Usage
Salmeterol is a LABA indicated for (1.1):
- Treatment of asthma in patients aged 4 years and older with an ICS.
- Prevention of exercise-induced bronchospasm (eib) in patients aged 4 years and older.
- Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
Limitations of use: Not indicated for relief of acute bronchospasm.
Mechanism of Action and Pharmacology
Salmeterol is a selective LABA. In vitro studies show salmeterol to be at least 50 times more selective for beta 2 -adrenoceptors than albuterol. Although beta 2 -adrenoceptors are the predominant adrenergic receptors in bronchial smooth muscle and beta 1 -adrenoceptors are the predominant receptors in the heart, there are also beta 2 -adrenoceptors in the human heart comprising 10% to 50% of the total beta-adrenoceptors. The precise function of these receptors has not been established, but their presence raises the possibility that even selective beta 2 -agonists may have cardiac effects. (1.1)
What is Asthma?
Asthma involves inflammation and narrowing of the airways. Controller and quick-relief treatments have distinct roles in an individualized action plan. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Asthma condition guide for appointment questions and related therapies (2.1).
What is COPD?
Chronic obstructive pulmonary disease causes persistent breathing limitation. Treatment can include inhaled medicines, smoking cessation, rehabilitation, and an exacerbation plan. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete COPD condition guide for appointment questions and related therapies (2.1).
Ordering Salmeterol from Canada for U.S. Delivery
U.S. patients can order Salmeterol (Salmeterol) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Salmeterol |
| Chemical / Generic Name | Salmeterol Xinafoate |
| Pharmacological Class | Respiratory medications and inhalers agent |
| Therapeutic Category | Respiratory medications and inhalers |
| Same-Ingredient Catalogue Entries | Serevent (Salmeterol Xinafoate) |
| Molecular Formula | C25H37NO4•C11H8O3 (2.1) |
| Molecular Weight | 603.8, g/mol (2.1) |
| Elimination Half-Life | ~5.5 hours (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Oral, Respiratory (Inhalation) |
| Dosage Forms & Strengths | Inhalation powder: Inhaler containing a foil blister strip of powder formulation for oral inhalation. The strip contains salmeterol 50 mcg per blister |
| Primary Indications | Specified Asthma Or Reversible-Airway Conditions And Chronic Obstructive Pulmonary Disease |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 6EW8Q962A5 |
| NLM RxNorm Concept ID (RxCUI) | 866048, 866049 |
| FDA Application License | NDA020692 |
| Official DailyMed SetID | 12d9728e-6b5c-4aee-bfb0-745e542ed2e4 |
| Catalogue Index Links | Letter S Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Should be administered by the orally inhaled route only. More frequent administration or a greater number of inhalations (more than 1 inhalation twice daily) is not recommended as some patients are more likely to experience adverse effects. Patients using Serevent Diskus should not use additional LABA for any reason (1.1):
- For oral inhalation only.
- Treatment of asthma in patients aged 4 years and older: 1 inhalation twice daily in addition to concomitant treatment with an ICS.
- Eib: 1 inhalation at least 30 minutes before exercise.
- Maintenance treatment of bronchospasm associated with COPD: 1 inhalation twice daily.
Presentations and Strengths
Inhalation powder: Inhaler containing a foil blister strip of powder formulation for oral inhalation. The strip contains salmeterol 50 mcg per blister. Inhalation powder: Inhaler containing salmeterol (50 mcg) as a powder formulation for oral inhalation. (1.1)
Administration Guidance
Administer Salmeterol strictly via the prescribed inhalation device according to the schedule set by your healthcare provider (1.1). Prime, load, inhale, and clean the inhaler exactly as shown in the manufacturer’s patient leaflet. If using an inhaled corticosteroid preparation, rinse your mouth with water and spit out after each dose when directed to reduce local throat irritation.
Missed Dose Guidance
If you miss a scheduled dose of Salmeterol, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Salmeterol is salmeterol xinafoate (2.1). Other catalogue entries containing salmeterol xinafoate include Serevent (Salmeterol Xinafoate).
Excipients and Formulation Carriers
Film coatings, stabilizers, and inactive carriers vary by strength and manufacturer presentation. If you have a known allergy to lactose, dyes, sulfites, or specific preservatives, ask our pharmacist to check the exact excipient list for your selected package (2.1).
Cautions and important safety information
Boxed Warning
Warning: asthma-related death Long-acting beta-2 adrenergic agonists (LABA), such as salmeterol, the active ingredient in Serevent Diskus, as monotherapy (without inhaled corticosteroids [ICS]) increase the risk of asthma-related death. Data from a large placebo-controlled U.S. Trial that compared the safety of salmeterol with placebo added to usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol (13 deaths out of 13,176 subjects treated for 28 weeks on salmeterol versus 3 deaths out of 13,179 subjects on placebo). Use of background ICS was not required in this study. (1.1)
Contraindications
Use of Serevent Diskus for the treatment of asthma without concomitant use of an ICS is contraindicated. The use of Serevent Diskus is contraindicated in the following conditions (1.1):
- Primary treatment of status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required.
- Severe hypersensitivity to milk proteins or demonstrated hypersensitivity to salmeterol or any of the excipients.
- Asthma: Without concomitant use of an ICS.
Key Clinical Precautions
Before starting or continuing Salmeterol, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Adherence to prescribed regimen: Take this medication strictly as prescribed by your healthcare provider and avoid excessive alcohol intake, which can increase metabolic or systemic side effects.
- Diabetic ketoacidosis (DKA): Ketoacidosis, a serious condition requiring urgent hospitalization, has been reported even when blood glucose readings are below 250 mg/dL. Risk factors include acute febrile illness, reduced caloric or fluid intake, pancreatic disorders, surgery, and insulin dose reduction.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
- Angioedema: Swelling of the face, extremities, lips, tongue, glottis, or larynx can occur at any time during treatment. Airway-involving angioedema requires emergency medical intervention.
- Seizure threshold: This medication may lower the seizure threshold or require caution in patients with a history of seizure disorders or conditions that predispose to seizures.
- Hypotension and volume depletion: Intravascular volume contraction can cause symptomatic low blood pressure, orthostatic dizziness, or fainting, especially in older adults, patients with impaired renal function, or those taking diuretics. Ensure adequate hydration before and during therapy.
Pregnancy, Lactation, and Special Populations
The available data from published epidemiological studies and case reports with use of Serevent Diskus in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Beta‑agonists may interfere with uterine contractility. There are clinical considerations in pregnant women with asthma. Oral administration of salmeterol to pregnant rabbits caused teratogenicity characteristic of beta‑adrenoceptor stimulation at maternal doses approximately 50 times the maximum recommended human daily inhaled dose (mrhdid) on an AUC basis. (1.1)
Interactions
Official Drug Interaction Overview
- Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir, ketoconazole): Use not recommended. May increase risk of cardiovascular effects.
- Monoamine oxidase inhibitors and tricyclic antidepressants: Use with extreme caution. May potentiate effect of salmeterol on vascular system.
- Beta-blockers: Use with caution. May block bronchodilatory effects of beta-agonists and produce severe bronchospasm.
- Diuretics: Use with caution. Electrocardiographic changes and/or hypokalemia associated with non-potassium-sparing diuretics may worsen with concomitant beta-agonists. (1.1)
Important Interaction Categories
Concomitant use of Salmeterol with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Potassium supplements, potassium-sparing diuretics (such as Aldactone (Spironolactone), eplerenone, triamterene, or amiloride), and salt substitutes: Concomitant use can lead to clinically significant hyperkalemia (elevated serum potassium). Regular electrolyte monitoring is recommended.
- Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.
- Strong CYP3A4 inhibitors and inducers (such as ketoconazole, itraconazole, clarithromycin, ritonavir, rifampin, carbamazepine, phenytoin, or St. John’s wort): Co-administration with strong CYP3A4 inhibitors can significantly increase plasma concentrations and side-effect risk, whereas CYP3A4 inducers can decrease systemic exposure and reduce efficacy.
Side effects
Like all medications, Salmeterol can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Skin rash: Mild skin eruptions can occur; seek immediate care if a rash blisters, peels, or is accompanied by fever.
- Peripheral edema (swelling of ankles, feet, or hands): Fluid retention may occur; notify your doctor if swelling is rapid or accompanied by shortness of breath.
Clinical Trial and Postmarketing Adverse Reactions
LABA, including salmeterol, the active ingredient in Serevent Diskus, as monotherapy (without ICS) increase the risk of asthma-related death. Data from a large 28-week placebo-controlled U.S. Trial that compared the safety of salmeterol or placebo added to usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol. Available data from controlled clinical trials suggest that LABA as monotherapy increase the risk of asthma-related hospitalization in pediatric and adolescent patients. Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. Most common adverse reactions (incidence ≥5%) are (1.1):
- Asthma: Headache, influenza, nasal/sinus congestion, pharyngitis, rhinitis, tracheitis/bronchitis.
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Diskus is supplied as a disposable teal green plastic inhaler containing a foil blister strip with 60 blisters. The inhaler is packaged in a plastic-coated, moisture-protective foil pouch (NDC 0173-0521-00). Store at room temperature between 68°F and 77°F (20°C and 25°C); excursions permitted from 59°F to 86°F (15°C to 30°C). Store in a dry place away from direct heat or sunlight. Keep out of reach of children. (1.1)
Store Salmeterol in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (salmeterol xinafoate) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Respiratory medications and inhalers directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Serevent (Salmeterol Xinafoate), listed in Respiratory medications and inhalers
- Acetylcysteine, listed in Respiratory medications and inhalers
- Advair Diskus (Fluticasone Propionate / Salmeterol Xinafoate), listed in Respiratory medications and inhalers
- Advair (Fluticasone Propionate / Salmeterol Xinafoate), listed in Respiratory medications and inhalers
- Breztri Aerosphere (Budesonide / Glycopyrrolate / Formoterol Fumarate), listed in Respiratory medications and inhalers
- Flovent (Fluticasone Propionate), listed in Respiratory medications and inhalers
Related Categories, Directories, and Ordering Guides
- Respiratory medications and inhalers Category Directory
- Medications Starting with S
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
- Explore Aldactone Spironolactone
Frequently Asked Questions About Salmeterol
What is Salmeterol and what active ingredient does it contain?
Salmeterol is a respiratory medications and inhalers agent containing the active pharmaceutical ingredient salmeterol xinafoate. It is supplied for oral, respiratory (inhalation) administration and requires a valid prescription where applicable.
How does Salmeterol work in the body?
Salmeterol is a selective LABA. In vitro studies show salmeterol to be at least 50 times more selective for beta 2 -adrenoceptors than albuterol. Although beta 2 -adrenoceptors are the predominant adrenergic receptors in bronchial smooth muscle and beta 1 -adrenoceptors are the predominant receptors in the heart, there are also beta 2 -adrenoceptors in the human heart comprising 10% to 50% of the total beta-adrenoceptors.
What conditions is Salmeterol prescribed to treat?
Salmeterol is primarily indicated for specified asthma or reversible-airway conditions and chronic obstructive pulmonary disease. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Salmeterol?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Salmeterol is administered via the oral, respiratory (inhalation) route. Use it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Salmeterol?
Commonly reported side effects of Salmeterol include feeling sick, vomiting, headache, dizziness, rash, and swelling. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Salmeterol?
Important interaction categories for Salmeterol include potassium-containing products, monoamine oxidase inhibitors, and medicines that strongly affect CYP3A enzymes. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Salmeterol be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Salmeterol to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Salmeterol online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Salmeterol (Salmeterol) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
What is the brand-name version of Salmeterol (Salmeterol) at a Canada pharmacy?
Salmeterol is a generic formulation containing Salmeterol. You can review all Salmeterol presentations in our Active Ingredient hub.
How is Salmeterol shipped to U.S. residents, and how much does shipping cost?
Salmeterol ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Salmeterol prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Salmeterol prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Salmeterol are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Salmeterol (Salmeterol Xinafoate), Official Prescribing Information. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Asthma. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: COPD. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
